Latest International Markets News

EZZ Life Science Holdings has secured a four-year exclusive global distribution agreement with Aumake Limited, committing to at least A$10 million in purchases. This partnership aims to accelerate EZZ’s international reach while preserving brand control.

Asset Vision has reported a robust 38% increase in annual recurring revenue to $5.2 million in the first half of FY26, underpinned by new council contracts and AI-driven platform upgrades. The company’s positive cash EBITDA and strategic focus on scalable growth signal strong momentum in the critical infrastructure SaaS market.

SEEK Limited posted strong half-year revenue growth and record dividends, but a hefty impairment charge on its Chinese associate Zhaopin led to a significant net loss. The company’s strategic platform unification and Sidekicker reacquisition underpin operational momentum despite macroeconomic headwinds.

Smart Parking Limited reported a robust half-year result for December 2025, nearly doubling revenue to $62.6 million and boosting adjusted EBITDA by 85%, driven by its US acquisition and international growth.

Estrella Resources has released promising initial assay results from its 2025 drilling campaign at the Werumata Limestone Project in Timor-Leste, confirming high-grade, low magnesium limestone and chalk deposits. The company aims for a JORC-compliant resource estimate of at least 500 million tonnes.

Ionic Rare Earths is advancing its rare earth magnet recycling ambitions with strategic leadership relocation, government recognition, and new funding discussions. The company’s Belfast facility gains global significance as it targets key international markets.

Wellnex Life Limited is exploring acquisition interest and convertible note funding to accelerate Pain Away's expansion and strengthen its financial footing, signaling a pivotal phase in its turnaround journey.

Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.

CAR Group Limited has reported a strong first half for FY26, posting 13% revenue growth and reaffirming its optimistic outlook for the full year, driven by strategic AI integration and global market expansion.

Memphasys has raised $800,000 through a share placement to accelerate the commercial expansion of its Felix™ System, following key regulatory approvals and initial revenue milestones.

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.

Pinnacle Investment Management reported an 11% drop in net profit after tax for the first half of FY26, despite record net inflows and a strategic move to fully acquire Pacific Asset Management.